DIN 02452359 — NAT-GRANISETRON 1 MG
NAT-GRANISETRON is a tablet of Granisetron marketed by NATCO PHARMA (CANADA) INC. The full Granisetron monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02452359
- Brand name
- NAT-GRANISETRON
- Active ingredient
- Granisetron
- Strength
- 1 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- NATCO PHARMA (CANADA) INC
- Health Canada status
- MARKETED
- Drug class
- Serotonin 5-HT3 receptor antagonist (antiemetic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Granisetron products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02308894 | APO-GRANISETRON | 1 MG | TABLET | APOTEX INC | MARKETED |
| 02322765 | GRANISETRON HYDROCHLORIDE INJECTION | 1 MG | LIQUID | OMEGA LABORATORIES LIMITED | MARKETED |
| 02472686 | JAMP GRANISETRON | 1 MG | TABLET | JAMP PHARMA CORPORATION | DORMANT |